Jean-Michel AUBRY  CV du Chef de Groupe  Composition du Groupe

  Coordonnées du groupe

Dr. J.-M. AUBRY
HUG/ Dpt Psychiatrie
Consultation Jonction
Bd St Georges 16-18
1205 Genève

Jean-Michel.Aubry@hcuge.ch

Tél.: + 41 22 327 75 65
Fax: + 41 22 327 75 99




Commentaires



Pages générées le 17.11.2015
Sujet de recherche | Publications du groupe | Domaines de recherche

Groupe de recherches sur les Thérapeutiques des Troubles de l'Humeur et Anxieux

Plusieurs projets de recherche sont en cours dans le cadre d'un groupe de recherche clinique de la Clinique de Psychiatrie Adulte (GRETTHA - Groupe de recherches sur les Thérapeutiques des Troubles de l'Humeur et Anxieux). Ce groupe est co-dirigé avec les Drs G. Bondolfi et J.-M. Aubry et bénéficie des contributions d'un réseau de jeunes médecins et psychologues cliniciens de la clinique. Toujours sur le principe du réseau, il tisse progressivement des liens avec des groupes de chercheurs en sciences de base (pharmacocinétique, neurobiologie, génétique).
Au sein des recherches du groupe GRETTHA, l'implication de l'intéressé concerne plus particulièrement l'évaluation et le traitement des troubles bipolaires et notamment la prévention des rechutes.




Publications du groupe

Lithium: updated human knowledge using an evidence-based approach: Part I: Clinical efficacy in bipolar disorder.
CNS DRUGS : THE CLINICAL REVIEW JOURNAL OF DRUGS AND THERAPEUTICS IN PSYCHIATRY AND NEUROLOGY
2009 vol. 23(3) pp. 225-240
GRANDJEAN EM, AUBRY JM

Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring.
CNS DRUGS : THE CLINICAL REVIEW JOURNAL OF DRUGS AND THERAPEUTICS IN PSYCHIATRY AND NEUROLOGY
2009 vol. 23(4) pp. 331-349
GRANDJEAN E, AUBRY JM

Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety.
CNS DRUGS : THE CLINICAL REVIEW JOURNAL OF DRUGS AND THERAPEUTICS IN PSYCHIATRY AND NEUROLOGY
2009 vol. 23(5) pp. 397-418
GRANDJEAN E, AUBRY JM

Performance of the Mood Disorder Questionnaire (MDQ) according to bipolar subtype and symptom severity.
EUROPEAN PSYCHIATRY : THE JOURNAL OF THE ASSOCIATION OF EUROPEAN PSYCHIATRISTS
2009 vol. 24(5) pp. 341-344
GERVASONI N, WEBER ROUGET B, MIGUEZ M, DUBUIS V, BIZZINI V, GEX-FABRY M, BONDOLFI G, AUBRY JM

[Screening for bipolar disorders: a review of the literature].
L'ENCEPHALE
2009 vol. 35(6) pp. 570-576
WEBER ROUGET B, AUBRY JM

Is there a place for tricyclic antidepressants and subsequent augmentation strategies in obtaining remission for patients with treatment resistant depression?
PHARMACOLOGICAL REVIEWS
2009 vol. 59(3) pp. 202-206
GERVASONI N, AUBRY JM, GEX-FABRY M, BERTSCHY G, BONDOLFI G

Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
2009 vol. 33(6) pp. 1017-1021
TRINGALI G, LISI L, DE SIMONE ML, AUBRY JM, PREZIOSI P, POZZOLI G, NAVARRA P

Early effects of mood stabilizers on the Akt/GSK-3 beta signaling pathway and on cell survival and proliferation
PSYCHOPHARMACOLOGY
2009 vol. 205(3) pp. 419-429
AUBRY JM, SCHWALD M, BALLMANN E, KAREGE F

Frequency of dysphoria and mixed states.
PSYCHOPATHOLOGY
2008 vol. 41(3) pp. 187-193
BERTSCHY G, GERVASONI N, FAVRE S, LIBEREK C, RAGAMA PARDOS EMNA, AUBRY JM, GEX-FABRY M, DAYER A

CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response.
THERAPEUTIC DRUG MONITORING
2008 vol. 30(4) pp. 474-482
GEX-FABRY M, EAP CB, ONEDA B, GERVASONI N, AUBRY JM, BONDOLFI G, BERTSCHY G

Phenomenology of mixed states: a principal component analysis study
BIPOLAR DISORDERS
2007 vol. 9 pp. 907-912
BERTSCHY, G, GERVASONI, N, FAVRE, S, LIBEREK, C, RAGAMA-PARDOS, E, AUBRY, JM, GEX-FABRY, M, DAYER, A

Efficacy of psychoeducational approaches on bipolar disorders: a review of the literature.
JOURNAL OF AFFECTIVE DISORDERS
2007 vol. 98(1-2) pp. 11-27
ROUGET BW, AUBRY JM

The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients
JOURNAL OF PSYCHIATRIC RESEARCH
2007 vol. 41 pp. 290-294
AUBRY JM, GERVASONI N, OSIEK C, PERRET G, ROSSIER MF, BERTSCHY G, BONDOLFI G

Time course of response to paroxetine: Influence of plasma level
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
2007 vol. 31 pp. 892-900
GEX-FABRY M, GERVASONI N, EAP CB, AUBRY JM, BONDOLFI G, BERTSCHY G

Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression
PSYCHONEUROENDOCRINOLOGY
2007 vol. 32(5) pp. 575-579
STEIMER T, PYTHON A, SCHULZ PE, AUBRY JM

No human tryptophan hydroxylase-2 gene R441H mutation in a large cohort of psychiatric patients and control subjects
BIOLOGICAL PSYCHIATRY
2006 vol. 60 pp. 202-203
DELORME R, DURAND CM, BETANCUR C, WAGNER M, RUHRMANN S, GRABE HJ, NYGREN G, GILLBERG C, LEBOYER M, BOURGERON T, COURTET P, JOLLANT F, BURESI C, AUBRY JM, BAUD P, BONDOLFI G, BERTSCHY G

Impact of the life goals group therapy program for bipolar patients: an open study
JOURNAL OF AFFECTIVE DISORDERS
2006 vol. 93(1-3) pp. 253-257
DENIS DE ANDRES RACHEL, AILLON NANCY, BARDIOT MARIE-CLAUDE, BOURGEOIS PATRICK, MERTEL STEFAN, NERFIN FREDERIC, ROMAILLER GLADYS, GEX-FABRY MARIANNE, AUBRY JEAN-MICHEL

Olanzapine plasma level in relation to antimanic effect in the acute therapy of manic states
NORDIC JOURNAL OF PSYCHIATRY
2006 vol. 60 pp. 181-182
BECH P, GEX-FABRY M, AUBRY JM, FAVRE S, BERTSCHY G

Lamotrigine inhibits basal and Na+-stimulated, but not Ca2+-stimulated, release of corticotropin-releasing hormone from the rat hypothalamus
PSYCHOPHARMACOLOGY
2006 vol. 188(3) pp. 386-392
TRINGALI GIUSEPPE, AUBRY JEAN-MICHEL, NAVARRA PIERLUIGI, POZZOLI GIACOMO

A stepwise drug treatment algorithm to obtain complete remission in depression: a Geneva study
SWISS MEDICAL WEEKLY
2006 vol. 136 pp. 78-85
BONDOLFI G, AUBRY JM, GOLAZ J, GEX-FABRY M, GERVASONI N, BERTSCHY G

Manic switch and serotonin syndrome with venlafaxine-lithium-valproate association
THERAPIE
2006 vol. 61(6) pp. 531-533
LIBEREK KRZYSZTOF, AUBRY JEAN-MICHEL, BAUD PATRICK

Efficacy and safety of olanzapine plus valproate in the treatment of acute mania: an open study
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
2003 vol. 7 pp. 131-134
AUBRY JM, RAGAMA-PARDOS E, FAVRE S, M MENZINGER, MUSCIONICO M, SANCHEZ S, GEX-FABRY M, FERRERO F, BERTSCHY G

Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism
PHARMACOGENOMICS
2003 vol. 3 pp. 101-104
ROUSSEVAL A, HENRY C., VAN DEN BULKE D., FOURNIER G., LAPLANCHE J.L., LEBOYER M., BELLIVIER F., AUBRY JEAN-MICHEL, BAUD P., BOUCHERIE M., BURESI C., FERRERO F, MALAFOSSE A.

Decreased serum brain-derived neurotrophic factor levels in major depressed patients
PSYCHIATRY RESEARCH
2002 vol. 109 pp. 143-148
KAREGE F, PERRET G, BONDOLFI G, SCHWALD M, BERTSCHY G, AUBRY JM

A theoretical reappraisal of mixed states: dysphoria as a third dimension
BIPOLAR DISORDERS
2000 vol. 2 pp. 316-324
DAYER A, AUBRY JM, ROTH L, DUCRET S, BERTSCHY G

Mania and hypomania induced by olanzapine or risperidone : a critical review of reported cases
THE JOURNAL OF CLINICAL PSYCHIATRY
2000 vol. 61 pp. 649-655
AUBRY JEAN-MICHEL, SIMON AE, BERTSCHY GILLES


Domaines de recherche